Post Profile






See more about: Kite Pharma

Related Posts


FASTER, PLEASE: Cancer cell therapies could be approved next year: Juno, Kite Pharma. A new wav…

US Politics / Conservative : Instapundit

FASTER, PLEASE: Cancer cell therapies could be approved next year: Juno, Kite Pharma. A new wave of experimental cancer drugs that directly recruit the immune system’s powerful T cells could begin reaching patients next year, accord...

Kite Pharma's CEO On Cancer-Killing T-Cells: 'This Is A Revolution'

Technology : Forbes: Tech

Expectations are high for Kite Pharma's experimental cancer treatment made from engineered T-cells, but so are worries about safety and long-term effectiveness.

Juno Therapeutics, Kite Pharma, & Petrobras Among the Morning’s Trending Stocks

Biotech Stock Kite Phama Explodes Higher After Good News About Its Non-Hodgkin's Lymphoma Drug (KITE, IBB)

Business & Finance : Business Insider: Clusterstock

Shares of Kite Pharma are exploding higher in after-hours trading. The $827 million biotech firm just revealed positive outcomes from patients with aggressive non-Hodgkin's lymphoma after receiving its anti-CD19 treatment. KITE is u...

Wildcat Capital Management Rides Kite Pharma Inc (KITE)’s Tide

Business & Finance / Investing : Insider Monkey

Kite Pharma Inc (NASDAQ:KITE) spiked as much as 18% during Thursday’s intraday trading before closing 15.73% higher at $73.51. The price action was brought about by Kite’s latest purchase of privately held T-Cell Factory B.V. (TCF),...

Comments


Copyright © 2016 Regator, LLC